The TRAIL protein, which was incorporated into the obtained gel-like mPEG-Coa droplets, was protected against protease activity by providing a long-term (14 days) sustained release and suppressed colon cancer cell recurrence as compared with free TRAIL. The gene discussed is TNFSF10; the disease is malignant colon neoplasm.